Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Shawn Fitzgerald Podcasts

show episodes
 
Artwork

1
Intentional Change

Shawn FitzGerald & Joshua McNary

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
Welcome to Intentional Change, the podcast dedicated to helping business owners and leaders navigate the complexities of growth, technology, and change with intentionality and purpose. Hosted by Shawn FitzGerald and Joshua McNary, this show dives deep into the strategies, tools, and mindsets that empower businesses to scale, adapt, and thrive in an ever-evolving landscape. Each episode offers a blend of thought-provoking discussions and expert guest interviews, delivering actionable insights ...
  continue reading
 
Jessamy Bagenal, Chloe Wilson, and Callum Davidson—editors at The Lancet—and Gavin Cleaver, The Lancet Group’s Audio Producer, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers topics that advance the field of medical research, from exploring treatments to examining drug trials, public health outbreaks to surgical techniques, and more.
  continue reading
 
Loading …
show series
 
Franck Morschhauser joins Ben Abbott of The Lancet to discuss the phase 3 EPCORE FL-1 study on epcoritamab, lenalidomide, and rituximab for relapsed or refractory follicular lymphoma, which is being presented at ASH 2025. Click here to read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02360-8/fulltext Continu…
  continue reading
 
Shun Lu joins Ben Abbott of The Lancet to discuss the phase 3 HARMONi-6 trial of ivonescimab plus chemotherapy as first-line treatment in advanced squamous non-small-cell lung cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ …
  continue reading
 
Neal Shore joins Ben Abbott of The Lancet to discuss the phase 3 POTOMAC trial of durvalumab plus BCG in BCG-naïve, high-risk non-muscle-invasive bladder cancer, which is being presented at ESMO 2025. Click here to read the full article Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/…
  continue reading
 
Host Joshua McNary chat with Michelle Owens, certified EOS implementer, business coach, facilitator, and founding partner of Slingshot25. Michelle brings decades of hands-on leadership experience, a passion for development, and a reputation for asking tough questions with care. She helps entrepreneurial teams get unstuck and achieve real traction u…
  continue reading
 
In this episode of Intentional Change, Shawn FitzGerald sits down with Vada Grantham, CEO of Revelations Research Solutions, to explore the power of asking better questions and listening to customers with intention. Vada shares how market research goes far beyond surveys—it’s about uncovering insights that reveal why people buy, what truly matters …
  continue reading
 
What if the greatest opportunity for your business is already within reach—but hidden in plain sight? In this episode of Intentional Change, Shawn FitzGerald digs deep with Mitchell Kearns, Technology & Commercialization Director at Iowa’s SBDC. Together, they discuss how the Iowa Small Business Development Center (SBDC) supports entrepreneurs as t…
  continue reading
 
Too many businesses run like high-performance sports cars with no clear destination—powerful, fast, but ultimately going nowhere. In this episode of Intentional Change, Shawn FitzGerald sit down with Rob Taylor, EOS Implementer and founder of Taylor Management Solutions, to explore why vision matters, how to align leadership teams, and what it take…
  continue reading
 
In this episode of Intentional Change, host Joshua McNary and co-host Shawn FitzGerald sit down with Lindsay Leahy, an executive coach, USA Today bestselling author, and founder of The Restoration Project. Often called a “business therapist” by her clients, Lindsay has a unique gift for guiding leaders through complexity and helping them rediscover…
  continue reading
 
Thinking about buying a business instead of building one from scratch? In this episode of Intentional Change, chiropractor and acquisition strategist Dr. Brett Vowles breaks down why most acquisitions fail—and how to avoid the biggest mistakes. He reveals the simple but powerful framework he uses to assess every opportunity: Plan, People, and Proce…
  continue reading
 
With the global burden of liver cancer growing, The Lancet has commissioned an international panel of experts to identify strategies to strengthen the prevention, surveillance, diagnosis, and treatment of liver cancer. Stephen Chan joins Ben Abbott of The Lancet to discuss the key messages of the Commission, which is published today on World Hepati…
  continue reading
 
Early detection of oesophageal adenocarcinoma improves outcomes. Patients with the precursor lesion, Barrett's oesophagus, are recommended to undergo regular endoscopic surveillance, a process that can be burdensome for patients and health services. Professor Rebecca Fitzgerald's team have developed a tool that may be able to improve Barrett's surv…
  continue reading
 
In this episode of Intentional Change, host Joshua McNary is joined by Sarah Young, author of Expansive Impact and founder of Zing Collaborative. Together, they dive into what it truly means to lead with compassion, courage, and clarity in everyday moments—whether you’re steering a growing business, scaling a team, or simply striving to show up mor…
  continue reading
 
Too many business owners avoid the hardest question until it’s too late: What’s your exit strategy? In this powerful episode of Intentional Change, host Shawn FitzGerald and co-host Joshua McNary talk with Christy Jones, founder of Clarity Business Coaching, about her remarkable journey from growing up in a family-owned auto body shop to building a…
  continue reading
 
In this episode of Intentional Change podcast, hosts Joshua McNary and Shawn FitzGerald are joined by Brad Farris of Anchor Advisors, a seasoned executive leadership coach known for helping founders break through the common growth ceilings in their businesses. They dig into practical approaches to leadership, including how to avoid the trap of over…
  continue reading
 
Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, and Katherine Gourd, Acting Deputy Editor at The Lancet Oncology, join Leon Terner to share some of their experiences, impressions and highlights from this year's American Society of Clinical Oncology (ASCO) conference. If you haven't already, be sure to list…
  continue reading
 
Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer. Read the full article: https://www.thelancet.com/journals/lancet/article/PI…
  continue reading
 
In this episode, host Shawn FitzGerald chats with leadership facilitator Steve Vaught to explore how meaningful relationships, safe spaces, and intentional communication create lasting impact in leadership. Steve shares why he regularly sends curated articles to peers—not as a strategy, but as a way to show care, spark conversation, and deepen conn…
  continue reading
 
Vania Wisdom, Senior Executive Editor at The Lancet and the journal's Oncology Ambassador, joins Gavin Cleaver to discuss what's being published at this year's American Society of Clinical Oncology (ASCO) meeting, what she's excited to see at the conference, and why ASCO is so important to the field. Continue this conversation on social! Follow us …
  continue reading
 
In this episode, host Shawn FitzGerald chats with Mike Wagner of White Rabbit Group to dive deep into the messy human side of leadership. Mike unpacks what leadership really means—and why it’s more about practice than position. He also walks through the four foundational habits every leader needs, how to build trust through regular feedback, and wh…
  continue reading
 
Networking often gets a bad rap, conjuring images of sales pitches, shallow transactions, and overwhelming social pressure. But as Danny Beyer —a financial advisor, mayor, author, and seasoned networker—shares, it doesn’t have to be that way. From busting the myth that networking is just about collecting business cards, to building authentic relati…
  continue reading
 
Welcome to another episode of Intentional Change, the podcast dedicated to guiding business owners and leaders through the challenges of growth, technology, and change with purpose and clarity. In this episode, we dive deep into the world of business communication with Shawn FitzGerald, a communication solutions consultant at Level Up Media Interac…
  continue reading
 
Welcome to the inaugural episode of "Intentional Change," hosted by Shawn FitzGerald. In this episode, we dive deep into the convoluted world of business technology with our guest, Joshua McNary, a seasoned business technologist. If you're a business owner who's feeling overwhelmed by the rapid evolution of tech tools or struggling to see the retur…
  continue reading
 
Francis Couturaud joins Chloe Wilson of The Lancet to discuss the RENOVE trial, which looks at assessing the efficacy and safety of reduced-dose versus full-dose direct oral anticoagulants in patients in whom extended anticoagulation has been indicated. Read the full paper: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02842-3/…
  continue reading
 
This week, we discuss treatment approaches for uncomplicated appendicitis in children following the publication of a trial in our January 18th issue. Lead author Shawn St Peter, general paediatric surgeon and surgeon-in-chief at Children’s Mercy Hospital, Kansas City, spoke with Callam Davidson about the motivation behind the study, key findings, a…
  continue reading
 
Michael Heneka joins Chloe Wilson and Bea Gomez Perez-Nievas of The Lancet to discuss a therapeutics paper discussing the opportunities and challenges of passive anti-amyloid β immunotherapy in Alzheimer's disease. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01883-X/fulltext?dgcid=buzzsprout_icw_podcast…
  continue reading
 
ROSHNI-2 was a multicentre, randomised controlled trial that investigated the efficacy of a culturally adapted, cognitive behavioural therapy-based intervention for postnatal depression in British south Asian women. Joining us to share their expertise and perspectives are chief investigator Professor Nusrat Husain, trial manager Farah Lunat, and se…
  continue reading
 
Rasha Al-Lamee and Shayna Chotai join Chloe Wilson of The Lancet to discuss ESC Congress 2024 highlights. The papers featured on this podcast are: 1) https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01733-1/fulltext 2) https://www.nejm.org/doi/abs/10.1056/NEJMoa2409134 3) https://www.thelancet.com/journals/lancet/article/PIIS0140-…
  continue reading
 
On August 14th, the World Health Organisation declared a public health emergency of international concern in relation to mpox. This was motivated, in part, by the emergence of a concerning new strain of mpox, clade 1b, which has spread rapidly across Central Africa. Joining me this week to discuss important clinical aspects of the current mpox outb…
  continue reading
 
Natasha Pocovi joins Chloe Wilson of The Lancet to discuss a trial investigating a walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack). Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00755-4?dgcid=buzzsprout_tlv_podcast_generic_lancet Continue this conv…
  continue reading
 
Prasad Kulkarni joins Callam Davidson of The Lancet to discuss the safety and immunogenicity of a bivalent conjugate vaccine against typhoid and paratyphoid, following the publication of a phase 1 trial. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00249-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_la…
  continue reading
 
Patricia Campbell and Frans Rutten join Chloe Wilson for an educationally-focused podcast, discussing the key messages for clinical practice on heart failure with preserved ejection fraction. Read the full Seminar: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02756-3/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continu…
  continue reading
 
Lene Seidler joins Callam Davidson of The Lancet to discuss umbilical cord clamping strategies at preterm birth following the publication of two systemic review and meta-analyses with individual participant data. Read the full articles: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02468-6/fulltext?dgcid=buzzsprout_icw_podcast_…
  continue reading
 
Emily Chew joins Chloe Wilson of The Lancet to discuss the future of treatments for geographic atrophy following the publication of two randomised controlled trials of new drug treatments. Read the full article here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01583-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Conti…
  continue reading
 
Simon Kyle joins Gavin Cleaver of The Lancet to discuss his paper on sleep restriction therapy as a new effective treatment for insomnia. Read the full article: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00683-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet Continue this conversation on social! Follow us today at... h…
  continue reading
 
On this International Women's Day, Lancet editors and the co-chairs of the Women and Cancer Commission discuss the burden of women’s cancer on society and reflect on the questions the Commission is trying to answer. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:…
  continue reading
 
Nick James discusses the key messages of the recent report from the STAMPEDE trial platform and the success of this platform in advancing the treatment of prostate cancer Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https:…
  continue reading
 
《柳叶刀》亚洲执行主编王辉对话《柳叶刀中国女性生殖、孕产妇、新生儿、儿童和青少年健康重大报告》共同主席乔杰院士。 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
  continue reading
 
Helena Wang discusses The Lancet Commission on women's reproductive, maternal, newborn, child and adolescent health (RMNCAH) in China with author Professor Jie Qiao. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://lin…
  continue reading
 
Siobhan Quenby & Arri Coomarasamy discuss the key findings from The Lancet's new Series on miscarriage. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv…
  continue reading
 
On the 50th anniversary of the Inverse Care Law, Professor Sir Muir Gray joins Gavin Cleaver to discuss the continuing importance of the ICL, and notions of value and quality in health care. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetm…
  continue reading
 
The Lancet's new Commission, Public Policy and Health in the Trump Era, looks back at the effects of the last four years on the health of the USA. One of the authors of the Commission, Mary Bassett (Harvard University) joins us to talk about the Commission findings and wider issues facing the USA. Continue this conversation on social! Follow us tod…
  continue reading
 
Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancet…
  continue reading
 
Renee Salas, leader of the Lancet Countdown policy brief in the US, discusses the climate problems facing the US, the issues of the last four years, and the reasons to be optimistic about the future. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/t…
  continue reading
 
Universal health coverage (UHC) is a vital facet of healthcare across the world, and a new Global Burden of Disease paper seeks to measure its spread. The Lancet spoke with author Rafael Lozano and linked Comment author Margaret Kruk about efforts to analyse and measure UHC. Continue this conversation on social! Follow us today at... https://thelan…
  continue reading
 
The Lancet Editor-in-Chief Richard Horton explains the current status of the Oxford and China COVID-19 vaccines, including an overview of current progress and the next steps for both. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicalj…
  continue reading
 
The new Global Burden of Disease paper forecasts major alterations in worldwide population over the next few decades. We ask Kathleen O’Reilly, of LSHTM, how models are made and how you account for a changing world, and we speak with paper author Stein Emil Vollset of IHME about the implications of his predictions. Continue this conversation on soc…
  continue reading
 
Professor Rosanna Peeling discusses the implications of seroprevalence results from recent COVID-19 antibody studies. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com…
  continue reading
 
The Asia Executive Editor of The Lancet, Helena Hui Wang, chats with Bin Cao about clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljour…
  continue reading
 
柳叶刀亚洲执行主编王辉跟曹彬教授关于2019冠状病毒感染住院患者临床发病过程和死亡危险因素的讨论 Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettvBy The Lancet
  continue reading
 
Richard Horton, Sarah Dalglish, and Grace Gatera talk about the future for children alive today, alongside findings from the new Commission. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lan…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play